Benefits of religious beliefs for cancer patients: A response to Dawkins and Hitchens Maurie Markman Editor’s Commentary 24 June 2008 Pages: 185 - 187
Adjuvant and neoadjuvant therapy of gastric cancer: A comparison of three pivotal studies Takeshi Sano OriginalPaper 24 June 2008 Pages: 191 - 198
The impact of new data in the treatment of advanced hepatocellular carcinoma Ghassan K. Abou-AlfaAlan P. Venook OriginalPaper 24 June 2008 Pages: 199 - 205
Intensity-modulated radiation therapy for gastrointestinal tumors Jeffrey J. MeyerBrian G. CzitoChristopher G. Willett OriginalPaper 24 June 2008 Pages: 206 - 211
Approaches to localized pancreatic cancer Martin LoosJörg KleeffMarkus W. Büchler OriginalPaper 24 June 2008 Pages: 212 - 219
Recent advances in the treatment of localized rectal cancer Jean-François BossetFrance NguyenBenjamin Schipman OriginalPaper 24 June 2008 Pages: 220 - 224
Potentially curable metastatic colorectal cancer Matthew H. G. KatzJean-Nicolas Vauthey OriginalPaper 24 June 2008 Pages: 225 - 231
The changing face of renal cell carcinoma pathology Hakan AydinMing Zhou OriginalPaper 24 June 2008 Pages: 235 - 244
Adjuvant therapy for renal cell carcinoma Naomi B. HaasRobert Uzzo OriginalPaper 24 June 2008 Pages: 245 - 252
Current status of debulking nephrectomy in the era of tyrosine kinase inhibitors Vitaly MargulisChristopher G. WoodSurena F. Matin OriginalPaper 24 June 2008 Pages: 253 - 258
The current role of immunotherapy for renal cell carcinoma in the era of targeted therapeutics Michael K. K. Wong OriginalPaper 24 June 2008 Pages: 259 - 263
The future of tyrosine kinase inhibitors: Single agent or combination? Keith T. Flaherty OriginalPaper 24 June 2008 Pages: 264 - 270
